2024-05-13 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $1.26 | $15,140 | +3.91% | |
2024-02-29 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $1.58 | $9,439 | -12.74% | |
2024-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $1.52 | $11,265 | -16.46% | |
2023-05-25 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $1.22 | $77,270 | +3.31% | |
2023-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $0.88 | $11,437 | +23.5% | |
2023-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $0.81 | $5,430 | +38.48% | |
2022-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $2.17 | $31,490 | -80.93% | |
2022-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $2.15 | $14,125 | -81.02% | |
2021-04-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $3.40 | $3,604 | -15.92% | |
2021-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $3.40 | $48,513 | -14.71% | |
2020-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | | $8.70 | $61,335 | -34.16% | |
2017-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $19.89 | $310,377 | -45.25% | |
2017-07-03 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $14.26 | $44,313 | -0.51% | |
2017-04-03 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $9.18 | $28,560 | +64.77% | |
2017-01-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $10.49 | $37,976 | | |
2016-10-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $8.95 | $27,867 | | |
2016-07-05 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $7.47 | $23,251 | +21.67% | |
2016-04-04 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $9.41 | $29,284 | -7.02% | |
2016-01-04 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $12.28 | $44,478 | -32.72% | |
2015-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | | $8.67 | $25,720 | -11.81% | |